Active Pharmaceutical Ingredients Market Size and Forecast 2024-2033|Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited

Overview and Scope

The active pharmaceutical ingredient (API) is any component or substance used in a finished pharmaceutical product (FPP) and is designed to have pharmacological action or otherwise have a direct impact on the treatment, mitigation, cure, or prevention of disease. It is also used for the restoration, correction, or modification of human physiological processes.

Sizing and Forecast

The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $218.45 billion in 2023 to $233.55 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in drug development, expansion of generic drug market, globalization of pharmaceutical manufacturing, regulatory initiatives for drug safety, rise in contract manufacturing organizations (cmos), focus on precision medicine, emergence of biopharmaceuticals, global pandemics and health threats.

The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $305.2 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing focus on rare diseases, expansion of biosimilars market, advancements in green chemistry, focus on continuous manufacturing, regulatory support for innovation, globalization of clinical trials, focus on sustainable and ethical practices.. Major trends in the forecast period include digitalization of drug development, investment in advanced manufacturing technologies, apis for rare diseases and orphan drugs, regulatory scrutiny on quality, api serialization and traceability, biopharmaceuticals and biotechnology products.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/active-pharmaceutical-ingredients-global-market-report

Segmentation & Regional Insights

The active pharmaceutical ingredients market covered in this report is segmented –

1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)

2) By Manufacturer: Captive Manufacturers, Merchant Manufacturers

3) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs

4) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications

North America was the largest region in the active pharmaceutical ingredients market share in 2023. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8539&type=smp

Major Driver Impacting Market Growth

The increasing incidence of chronic diseases is expected to propel the growth of the active pharmaceutical ingredients market going forward. Chronic disease is one that often lasts for three months or longer and may worsen with time. Cancer, heart disease, stroke, diabetes, and arthritis are the most prevalent chronic diseases. APIs are used in high-quality medications that address oncology, cardiology, neurology, orthopedic, and other illnesses. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation (IDF), a Belgium-based global organization to advocate for the global treatment, control, and cure of diabetes, by 2030, the number of people with diabetes is expected to increase to 578 million, and 700 million by 2045. Nearly half of deaths from diabetes occur in adults under the age of 60, making it one of the top 10 killers. Therefore, increasing incidence of chronic diseases will drive the growth of the active pharmaceutical ingredients market.

Key Industry Players

Major companies operating in the active pharmaceutical ingredients market report are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF Corporation, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline plc, Godrej Consumer Products, Roche Holding AG, Daiichi Sankyo Inc., Catalent Inc.

The active pharmaceutical ingredients market report table of contents includes:

1. Executive Summary

2. Active Pharmaceutical Ingredients Market Characteristics

3. Active Pharmaceutical Ingredients Market Trends And Strategies

4. Active Pharmaceutical Ingredients Market – Macro Economic Scenario

5. Global Active Pharmaceutical Ingredients Market Size and Growt

26. South America Active Pharmaceutical Ingredients Market

27. Brazil Active Pharmaceutical Ingredients Market

28. Middle East Active Pharmaceutical Ingredients Market

29. Africa Active Pharmaceutical Ingredients Market

30. Active Pharmaceutical Ingredients Market Competitive Landscape And Company Profiles

Top Major Players: